Результаты поиска - Sadayoshi Ito

Отмена результатов
  1. 1
    Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics.

    Evidence for the role of nitric oxide in macula densa control of glomerular hemodynamics. по Sadayoshi Ito, Yufeng Ren

    Опубликовано 1993
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  2. 2
    Pulse Pressure Amplification, Arterial Stiffness, and Peripheral Wave Reflection Determine Pulsatile Flow Waveform of the Femoral Artery

    Pulse Pressure Amplification, Arterial Stiffness, and Peripheral Wave Reflection Determine Pulsatile Flow Waveform of the Femoral Artery по Junichiro Hashimoto, Sadayoshi Ito

    Опубликовано 2010
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  3. 3
    Aortic Stiffness Determines Diastolic Blood Flow Reversal in the Descending Thoracic Aorta

    Aortic Stiffness Determines Diastolic Blood Flow Reversal in the Descending Thoracic Aorta по Junichiro Hashimoto, Sadayoshi Ito

    Опубликовано 2013
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  4. 4
    Central Pulse Pressure and Aortic Stiffness Determine Renal Hemodynamics

    Central Pulse Pressure and Aortic Stiffness Determine Renal Hemodynamics по Junichiro Hashimoto, Sadayoshi Ito

    Опубликовано 2011
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  5. 5
    An in vitro approach to the study of macula densa-mediated glomerular hemodynamics

    An in vitro approach to the study of macula densa-mediated glomerular hemodynamics по Sadayoshi Ito, Oscar A. Carretero

    Опубликовано 1990
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  6. 6
    Role of the macula densa in renin release.

    Role of the macula densa in renin release. по Sadayoshi Ito, Oscar A. Carretero

    Опубликовано 1985
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  7. 7
    Eight and 12 week courses of cyclophosphamide in nephrotic syndrome.

    Eight and 12 week courses of cyclophosphamide in nephrotic syndrome. по Naoshi Ueda, K Kuno, Sadayoshi Ito

    Опубликовано 1990
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  8. 8
    Possible role of adenosine in the macula densa mechanism of renin release in rabbits.

    Possible role of adenosine in the macula densa mechanism of renin release in rabbits. по Sadayoshi Ito, Oscar A. Carretero, Robert Murray

    Опубликовано 1985
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  9. 9
    Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole.

    Modulation of angiotensin II-induced vasoconstriction by endothelium-derived relaxing factor in the isolated microperfused rabbit afferent arteriole. по Sadayoshi Ito, Cynthia S. Johnson, Oscar A. Carretero

    Опубликовано 1991
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  10. 10
    Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk

    Strain vessel hypothesis: a viewpoint for linkage of albuminuria and cerebro-cardiovascular risk по Sadayoshi Ito, Tasuku Nagasawa, Michiaki Abe, Takefumi Mori

    Опубликовано 2009
    Полный текст Полный текст
    Revisão
    Добавить в Избранное
    Сохранить в:
  11. 11
    Efficacy and safety of esaxerenone (CS-3150) for the treatment of essential hypertension: a phase 2 randomized, placebo-controlled, double-blind study

    Efficacy and safety of esaxerenone (CS-3150) for the treatment of essential hypertension: a phase 2 randomized, placebo-controlled, double-blind study по Sadayoshi Ito, Hiroshi Itoh, Hiromi Rakugi, Yasuyuki Okuda, Satoru Yamakawa

    Опубликовано 2019
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  12. 12
    Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria

    Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria по Sadayoshi Ito, Kenichi Shikata, Masaomi Nangaku, Yasuyuki Okuda, Tomoko Sawanobori

    Опубликовано 2019
    Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  13. 13
    Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label study

    Efficacy and safety of dosage-escalation of low-dosage esaxerenone added to a RAS inhibitor in hypertensive patients with type 2 diabetes and albuminuria: a single-arm, open-label... по Hiroshi Itoh, Sadayoshi Ito, Hiromi Rakugi, Yasuyuki Okuda, Satoshi Nishioka

    Опубликовано 2019
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  14. 14
    Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension

    Long-term phase 3 study of esaxerenone as mono or combination therapy with other antihypertensive drugs in patients with essential hypertension по Hiromi Rakugi, Sadayoshi Ito, Hiroshi Itoh, Yasuyuki Okuda, Satoru Yamakawa

    Опубликовано 2019
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  15. 15
    Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction

    Antihypertensive effects and safety of esaxerenone in patients with moderate kidney dysfunction по Sadayoshi Ito, Hiroshi Itoh, Hiromi Rakugi, Yasuyuki Okuda, Setsuko Iijima

    Опубликовано 2020
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  16. 16
    Flow modulates myogenic responses in isolated microperfused rabbit afferent arterioles via endothelium-derived nitric oxide.

    Flow modulates myogenic responses in isolated microperfused rabbit afferent arterioles via endothelium-derived nitric oxide. по Luis A. Juncos, James H. Garvin, Oscar A. Carretero, Sadayoshi Ito

    Опубликовано 1995
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  17. 17
    Angiotensin II Type 1 Receptor Blockers Reduce Urinary Oxidative Stress Markers in Hypertensive Diabetic Nephropathy

    Angiotensin II Type 1 Receptor Blockers Reduce Urinary Oxidative Stress Markers in Hypertensive Diabetic Nephropathy по Susumu Ogawa, Takefumi Mori, Kazuhiro Nako, T. KATO, Kazuhisa Takeuchi, Sadayoshi Ito

    Опубликовано 2006
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  18. 18
    The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome

    The glucagon-like peptide-1 analog liraglutide suppresses ghrelin and controls diabetes in a patient with Prader-Willi syndrome по Miho Senda, Susumu Ogawa, Kazuhiro Nako, Masashi Okamura, Takuya Sakamoto, Sadayoshi Ito

    Опубликовано 2012
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  19. 19
    A novel bioactive haemodialysis system using dissolved dihydrogen (H2) produced by water electrolysis: a clinical trial

    A novel bioactive haemodialysis system using dissolved dihydrogen (H2) produced by water electrolysis: a clinical trial по Masaaki Nakayama, Hideki Nakano, Hiromi Hamada, Noritomo Itami, Ryoichi Nakazawa, Sadayoshi Ito

    Опубликовано 2010
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:
  20. 20
    Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study)

    Double-Blind Randomized Phase 3 Study Comparing Esaxerenone (CS-3150) and Eplerenone in Patients With Essential Hypertension (ESAX-HTN Study) по Sadayoshi Ito, Hiroshi Itoh, Hiromi Rakugi, Yasuyuki Okuda, M. Yoshimura, Satoru Yamakawa

    Опубликовано 2019
    Полный текст Полный текст
    Artigo
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: